Tyra Biosciences, Inc. TYRA Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Tyra Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tyra Biosciences, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tyra Biosciences, Inc.'s total liabilities?
- Tyra Biosciences, Inc. (TYRA) reported total liabilities of $24.47M in Q1 2026.
- How has Tyra Biosciences, Inc.'s total liabilities changed year-over-year?
- Tyra Biosciences, Inc.'s total liabilities increased by 22.7% year-over-year, from $19.94M to $24.47M.
- What is the long-term trend for Tyra Biosciences, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Tyra Biosciences, Inc.'s total liabilities has grown at a 63.6% compound annual growth rate (CAGR), from $2M to $23.43M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.